FYERS
Godavari Drugs140.00
+0.00 (+0.00%)

Godavari Drugs Share Price

140.00+0.00 (+0.00%)
+71.57% past 1 Year

Corporate filings & documents

Announcements

Voting Results & Scrutinizer Report of 38th Annual General Meeting of Godavari Drugs Limited
2 weeks ago
Voting Results & Scrutinizer Report of 38th Annual General Meeting of Godavari Drugs Limited
2 weeks ago
Proceedings of the 38th AGM held on 25.09.2026
2 weeks ago
Proceedings of the 38th AGM held on 25.09.2026
2 weeks ago
Intimation of Closure of Trading Window with effect from 1st October 2026 for the purpose of consideration and approval of the unaudited Financials for the quarter and half year ended 30th September 2026
2 weeks ago
Intimation of Closure of Trading Window with effect from 1st October 2026 for the purpose of consideration and approval of the unaudited Financials for the quarter and half year ended 30th September 2026
2 weeks ago
We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains details to access the notice and Annual Report for the Financial year 2025-26 on the companys Website
1 month ago
We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains details to access the notice and Annual Report for the Financial year 2025-26 on the companys Website
1 month ago
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions
1 month ago
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions
1 month ago
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance with Circulars issued by the MCA and SEBI. The Annual Report containing 38th AGM is also uploaded on the Companies Website and the same shall also be available on the website of NSDL.
1 month ago
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance with Circulars issued by the MCA and SEBI. The Annual Report containing 38th AGM is also uploaded on the Companies Website and the same shall also be available on the website of NSDL.
1 month ago
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.
1 month ago
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.
1 month ago
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking record of the Members of the Company for the purpose of 38th AGM to be held on 25.09.2026 at 03.00 p.m. Cut off date - 18.09.2026 Evoting Period 22.09.2026 to 24.09.2026 Evoting time 9.00 a.m. End 5.00 p.m
1 month ago
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking record of the Members of the Company for the purpose of 38th AGM to be held on 25.09.2026 at 03.00 p.m. Cut off date - 18.09.2026 Evoting Period 22.09.2026 to 24.09.2026 Evoting time 9.00 a.m. End 5.00 p.m
1 month ago
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs Shareholders in a 38th Annual General Meeting and any other regulatory authority and consequent amendments to the Memorandum of Association of the Company will be done.
1 month ago
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs Shareholders in a 38th Annual General Meeting and any other regulatory authority and consequent amendments to the Memorandum of Association of the Company will be done.
1 month ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we inform that the Board of Directors at its meeting held on 31st August 2026 approved the following:1. Alteration of the Main Objects Clause III(A) of the Memorandum of Association by inserting a new Main Object No. 4 relating to nutraceuticals natural extracts and food ingredients subject to approval of Members by Special Resolution at the ensuing 38th Annual General Meeting.2. Revised Notice of the 38th Annual General Meeting to be held on 25th September 2026.
1 month ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we inform that the Board of Directors at its meeting held on 31st August 2026 approved the following:1. Alteration of the Main Objects Clause III(A) of the Memorandum of Association by inserting a new Main Object No. 4 relating to nutraceuticals natural extracts and food ingredients subject to approval of Members by Special Resolution at the ensuing 38th Annual General Meeting.2. Revised Notice of the 38th Annual General Meeting to be held on 25th September 2026.
1 month ago
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
1 month ago
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
1 month ago
Newspaper Publication of Unaudited Results for quarter ended 30.06.2026
1 month ago
Newspaper Publication of Unaudited Results for quarter ended 30.06.2026
1 month ago
Board of Directors of the Company in its meeting held on Friday 14th August 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7 86 690 Equity Shares at an issue price of Rs.89/- each to Promoters Category on Preferential Basis
1 month ago
Board of Directors of the Company in its meeting held on Friday 14th August 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7 86 690 Equity Shares at an issue price of Rs.89/- each to Promoters Category on Preferential Basis
1 month ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026
1 month ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026
1 month ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026 and Allotment of Equity Shares on conversion of 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 10/- each) to Promoters Category on preferential basis
1 month ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026 and Allotment of Equity Shares on conversion of 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 10/- each) to Promoters Category on preferential basis
1 month ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Update on board meeting - Intimation of the Board Meeting of Godavari Drugs Limited (the Company) to be held on Friday August 14th 2026
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Update on board meeting - Intimation of the Board Meeting of Godavari Drugs Limited (the Company) to be held on Friday August 14th 2026
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months ago
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018
3 months ago
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018
3 months ago
Intimation of Closure of Trading window for the quarter ended June 30 2026
3 months ago
Intimation of Closure of Trading window for the quarter ended June 30 2026
3 months ago
Please find the enclosed newspaper publication for your information
4 months ago
Refer Enclosed
4 months ago
Company in its Board Meeting has approved financial results for period ended 31st march 2026
4 months ago
Company in its Board Meeting has approved financial results for period ended 31st march 2026
4 months ago
We are enclosing Audited Financial Results for the Quarter ended 31st march 2026 which are approved in Board Meeting which was held today i.e Wednesday 27th Day of May 2026
4 months ago
We are enclosing Audited Financial Results for the Quarter ended 31st march 2026 which are approved in Board Meeting which was held today i.e Wednesday 27th Day of May 2026
4 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the financial results for the fourth quarter and financial year ended March 31 2026.
4 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the financial results for the fourth quarter and financial year ended March 31 2026.
4 months ago
Annual Secretarial Compliance Report for the year ended 31st March 2026
4 months ago
Annual Secretarial Compliance Report for the year ended 31st March 2026
4 months ago
Reply to the BSE Query seeking Clarification on Price Movement
5 months ago
The Exchange has sought clarification from Godavari Drugs Ltd on April 17 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Godavari Drugs Ltd Share Price Today

The Godavari Drugs Ltd share price today is ₹118.1. During the trading session, the Godavari Drugs Ltd share price opened at ₹121 and recorded an intraday high of ₹127.5 and a low of ₹116.8. Last closing price was ₹120.62. Over the past 52 weeks, the Godavari Drugs Ltd share price has ranged between ₹69.7 and ₹135.25. The current Godavari Drugs Ltd stock price reflects real-time market activity based on executed trades on the exchange.